SBC Medical Group (NASDAQ:SBC) Shares Down 1.2% - Time to Sell?

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report)'s stock price traded down 1.2% during trading on Wednesday . The stock traded as low as $4.73 and last traded at $4.92. 109,856 shares traded hands during mid-day trading, an increase of 46% from the average session volume of 75,257 shares. The stock had previously closed at $4.98.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen upgraded SBC Medical Group to a "strong-buy" rating in a report on Saturday, June 21st.

SBC Medical Group Trading Down 2.3%

The company has a current ratio of 4.44, a quick ratio of 4.40 and a debt-to-equity ratio of 0.03. The company's 50 day moving average is $4.67 and its 200-day moving average is $4.30.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last announced its earnings results on Thursday, May 15th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.10. The business had revenue of $47.33 million for the quarter, compared to analysts' expectations of $51.52 million. On average, equities analysts expect that SBC Medical Group Holdings Incorporated will post 5.02 EPS for the current fiscal year.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.